Alteration of type A behavior and its effect on cardiac recurrences in post myocardial infarction patients: summary results of the recurrent coronary prevention project

American Heart Journal
M FriedmanW S Breall

Abstract

One thousand thirteen post myocardial infarction patients were observed for 4.5 years to determine whether their type A (coronary-prone) behavior could be altered and the effect such alteration might have on the subsequent cardiac morbidity and mortality rates of these individuals. Eight hundred sixty-two of these individuals were randomly assigned either to a control section of 270 participants who received group cardiac counseling or an experimental section of 592 participants who received both group cardiac counseling and type A behavioral counseling. The remaining 151 patients, serving as a "comparison group," did not receive group counseling of any kind. Using the "Intention-to-Treat" principle, we observed markedly reduced type A behavior at the end of 4.5 years in 35.1% of participants given cardiac and type A behavior counseling compared with 9.8% of participants given only cardiac counseling. The cumulative 4.5-year cardiac recurrence rate was 12.9% in the 592 participants in the experimental group that received type A counseling. This recurrence rate was significantly less (p less than 0.005) than either the recurrence rate (21.2%) observed in the 270 participants in the control group or the recurrence rate (28.2%) in...Continue Reading

References

Oct 1, 1978·Circulation·J A BlumenthalL W Thompson
Jan 27, 1975·JAMA : the Journal of the American Medical Association
Mar 21, 1985·The New England Journal of Medicine·R B CaseUNKNOWN Multicenter Post-Infarction Research Group
Aug 15, 1985·The New England Journal of Medicine
Sep 1, 1985·American Heart Journal·J J GillF R Drews
Jun 1, 1972·Proceedings of the Society for Experimental Biology and Medicine·M FriedmanR H Rosenman
May 11, 1970·JAMA : the Journal of the American Medical Association·M FriedmanF R Elevitch
Mar 22, 1984·The New England Journal of Medicine·UNKNOWN CASS Principal Investigators and Their Associates
Aug 30, 1984·The New England Journal of Medicine·W RubermanB S Chaudhary
Feb 15, 1980·JAMA : the Journal of the American Medical Association
Jun 1, 1949·The Journal of Nervous and Mental Disease·E FRIEDMAN
Nov 1, 1962·British Heart Journal·A A PeelJ L Dall

❮ Previous
Next ❯

Citations

Jul 1, 1996·Rehabilitation Nursing : the Official Journal of the Association of Rehabilitation Nurses·L R Delunas
Apr 1, 1991·Journal of Behavioral Medicine·R P Nolan, A T Wielgosz
Feb 1, 1992·Journal of Behavioral Medicine·B H Kaplan
Sep 1, 1994·Biofeedback and Self-regulation·W Linden
Dec 1, 1994·Journal of Behavioral Medicine·T Q Miller
Oct 1, 1996·Journal of Behavioral Medicine·M W KettererC J Voight
Jun 1, 1995·Journal of Clinical Psychology in Medical Settings·M WestC S Brewis
Jul 1, 1994·Journal of General Internal Medicine·H C Bucher
Aug 2, 2007·Heart Failure Reviews·Mark W Ketterer, Walter Knysz
Jun 22, 2011·Journal of Religion and Health·Laura J LutjenKevin J Flannelly
May 1, 1993·Journal of Psychosomatic Research·J Hunt, G Waller
May 1, 1993·Journal of Psychosomatic Research·A B LittmanR A MacLaughlin
Apr 1, 1994·Journal of Psychosomatic Research·P Bennett, D Carroll
Jan 1, 1989·Pharmacology & Therapeutics·J M Cruickshank, J C Smith
Oct 1, 1989·Journal of the American College of Cardiology·J A BlumenthalC B Taylor
May 23, 2001·Atherosclerosis·B SparagonG Ghandour
Aug 1, 1997·Journal of Psychosomatic Research·A LahadD L Patrick
Nov 14, 1997·Social Science & Medicine·R A MilliganM P Gracey
Nov 16, 2002·Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association·Raymond NiauraScott Weiss
Oct 1, 1994·Journal of Sports Sciences·L A SchmiedE A Sykes
Jul 27, 2010·Journal of Health Care Chaplaincy·Loren ToussaintFrederic Luskin
Sep 11, 2008·International Journal of Epidemiology·John Gallacher
Mar 31, 1999·The Journal of Cardiovascular Nursing·E F Buselli, E M Stuart
Jul 3, 2003·The Journal of Cardiovascular Nursing·Eileen M Stuart-ShorDaniel E Forman
Apr 9, 2005·Journal of Cardiopulmonary Rehabilitation·Maria ClaessonGunilla Burell
Mar 11, 2010·Journal of Cardiopulmonary Rehabilitation and Prevention·James A BlumenthalAndrew Sherwood
Feb 7, 2007·Current Opinion in Psychiatry·Erin M FeketeNeil Schneiderman
May 29, 2003·The British Journal of Ophthalmology·J M Jumper
Jul 11, 1987·British Medical Journal·T Sensky
Oct 29, 1994·BMJ : British Medical Journal·A D Flapan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.